[Rapporto di ricerca] Si prevede che il mercato dell'infertilità maschile raggiungerà i 6.213,96 milioni di dollari entro il 2027 rispetto ai 3.883,82 milioni di dollari del 2019; si stima che crescerà a un CAGR del 6,2% dal 2020 al 2027.
Fattori come l'aumento dell'infertilità maschile in tutto il mondo e i progressi tecnologici guidano la crescita del mercato. Tuttavia, il costo elevato delle procedure ostacola la crescita del mercato dell'infertilità maschile.
Mercati regionali redditizi per l'infertilità maschile
< p> Market Insights
Aumento della fertilità maschile in tutto il mondo
L'infertilità maschile è un problema globale con percentuali di prevalenza che variano da una regione all'altra. Le carenze e la scarsa qualità dello sperma sono le principali cause di infertilità negli uomini. Secondo il National Institutes of Health (NIH), nel 2016 l’infertilità ha colpito circa il 15% delle coppie, ovvero circa 48,5 milioni di coppie, in tutto il mondo. Inoltre, secondo un sondaggio pubblicato sul Journal of Reproductive Biology and Endocrinology, nel 2016, l’infertilità il tasso tra gli uomini è risultato più elevato in Africa e nell’Europa centrale/orientale. Secondo l’Organizzazione Mondiale della Sanità (OMS), nel 20% circa delle coppie infertili il problema riguarda i partner maschi, mentre nel 30% delle coppie il problema riguarda entrambi i partner. Pertanto, gli uomini contribuiscono a circa il 50% dei casi di infertilità a livello globale. Inoltre, secondo Healthy Male Andrology Australia, una divisione finanziata dal Dipartimento della Salute del governo australiano, circa 1 maschio su 20 produce un basso numero di spermatozoi, che porta alla sterilità, e 1 uomo su circa 100 non ha affatto spermatozoi.
Alcuni dei fattori comuni responsabili dell'infertilità negli uomini includono bassi livelli di produzione ormonale nella ghiandola pituitaria, problemi sessuali che influenzano l'ingresso dello sperma nel tratto vaginale e presenza degli anticorpi dello sperma. Il varicocele, cioè la presenza di vene dilatate nei testicoli, è la causa più comune di basso numero di spermatozoi negli uomini. Secondo il Dipartimento della salute e dei servizi umani degli Stati Uniti, il varicocele è presente in circa il 40% degli uomini che soffrono di problemi di infertilità.
Pertanto, l'incredibile prevalenza dell'infertilità maschile è generando una maggiore domanda di trattamenti e servizi per l'infertilità maschile.
Approfondimenti basati su test
Il mercato globale dell'infertilità maschile, basato sui test, è segmentato in base al DNA tecnica di frammentazione, analisi dello stress ossidativo, analisi dello sperma assistita da computer, esame microscopico, agglutinazione degli spermatozoi, test di penetrazione degli spermatozoi e altri. Il segmento della tecnica di frammentazione del DNA ha detenuto la quota maggiore del mercato nel 2019; considerando che si prevede che il segmento dell'analisi dello sperma assistita da computer registrerà il CAGR più elevato del mercato durante il periodo di previsione.
Mercato globale dell'infertilità maschile, per test: 2019 e 2027
Approfondimenti basati sul tipo di trattamento
Il mercato dell'infertilità maschile, in base al tipo di trattamento, è suddiviso in tecnologia di riproduzione assistita, chirurgia del varicocele e farmaci. Il segmento della tecnologia di riproduzione assistita e della chirurgia del varicocele ha detenuto una quota maggiore del mercato nel 2019 e si prevede che registrerà un CAGR più elevato nel mercato durante il periodo di previsione.
Distribuzione Approfondimenti basati sul canale
Il mercato dell'infertilità maschile, in base al canale di distribuzione, è segmentato in farmacie ospedaliere, farmacie e parafarmacie e farmacie online. Nel 2019, il segmento delle farmacie ospedaliere deteneva la quota maggiore del mercato. Inoltre, si stima che il mercato per lo stesso segmento crescerà al CAGR più elevato nel corso del 2020-2027.
Approfondimenti basati sugli utenti finali
Il Il mercato dell’infertilità maschile, in base all’utente finale, è segmentato in centri di fertilità, ospedali e cliniche, istituti di ricerca e altri utenti finali. Nel 2019, il segmento dei centri di fertilità deteneva la quota maggiore del mercato. Inoltre, si prevede che lo stesso segmento registrerà il CAGR più elevato del mercato, pari al 6,8%, nel periodo dal 2020 al 2027.
Approfondimenti strategici
Aziende come poiché Vitrolife e Halotech DNA hanno adottato diverse strategie inorganiche e organiche per aumentare i propri ricavi e la propria posizione nel mercato dell'infertilità maschile. Le prestazioni coinvolte dei principali attori hanno portato alla disponibilità di servizi e prodotti migliori sul mercato.
Mercato dell'infertilità maschile: mediante test
- Tecnica di frammentazione del DNA
- Analisi dello stress ossidativo
- Esame microscopico
- Agglutinazione degli spermatozoi
- Analisi dello sperma assistita da computer
- Saggio di penetrazione dello sperma
- Altro
Mercato dell'infertilità maschile - per tipo di trattamento
- Tecnologia di riproduzione assistita
- Fecondazione in vitro (IVF)
- Iniezione intracitoplasmatica dello sperma (ICSI)
- Chirurgia del varicocele
- Farmaci
Mercato dell'infertilità maschile - per canale di distribuzione
- Farmacie ospedaliere
- Farmacie e parafarmacie
- Farmacie online
Uomo Mercato dell'infertilità - per utente finale
- Ospedali e cliniche
- Centri per la fertilità
- Istituti di ricerca
- Altri utenti finali
- Nord America
- Stati Uniti
- Canada
- Messico
< li>Europa - Germania
- Regno Unito
- Francia
- Italia
- Spagna
- Svezia
- Danimarca
- Polonia
- Turchia
- Paesi Bassi
- Belgio
- Finlandia< /li>
- Svizzera
- Irlanda
- Norvegia
- Resto d'Europa
- Asia Pacifico (APAC)
- Giappone
- Cina
- India
- Corea del Sud
- Australia
- Thailandia
- Singapore
- Nuova Zelanda
- Vietnam
- Resto dell'Asia Pacifico
< li>Medio Oriente e Africa (MEA) - Emirati Arabi Uniti
- Arabia Saudita
- Sudafrica
- Egitto
- Israele
- Resto del Medio Oriente e dell'Africa
- America centrale e meridionale (SCAM)
- Brasile
- Argentina
- Resto dell'America centrale e meridionale
- MERCK KGaA
- Sanofi
- Bayer AG
- Endo Pharmaceuticals Inc.
- SCSA Diagnostics, Inc. < li>Soluzioni per l'andrologia
- Halotech DNA
- INTAS PHARMACEUTICALS LTD.
- Cadila Pharmaceuticals Ltd.
- Vitrolife
Mercato dell'infertilità maschile - per area geografica
Profili aziendali
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Male infertility is due to low sperm production, abnormal sperm function or blockages that prevent the delivery of sperm. Illnesses, injuries, chronic health problems, lifestyle choices such as Smoking, drinking alcohol, and taking certain medications can lower sperm numbers. Other causes of low sperm numbers include long-term sickness (such as kidney failure), childhood infections (such as mumps), and chromosome or hormone problems (such as low testosterone). In over a third of infertility cases, the problem is with the man. This is most often due to problems with the sperm production or with sperm delivery.
The male infertility market is estimated to grow owing to key driving factors such as increasing infertility rate, rising adoption of assisted reproductive technologies (ART), and a shift towards sedentary lifestyle across the globe. However, high cost of the procedures is likely to hamper the growth of the market during the forecast period.
Global male infertility market is segmented by region into North America, Europe, Asia-Pacific, Middle East & Africa and South & Central America. In North America, the U.S. holds a significant share of the male infertility market. Innovations in the product line primarily drive the growth of the market in the country. The country focuses on changing the overall landscape and the best in the class healthcare infrastructure, advanced facilities, and awareness and openness amongst citizens towards the disease.The increasing infertility rate in the country is the primary factor driving growth during the study period. For instance, Infertility is a common problem, with more than 5 million couples in the United States dealing with these problems. It affects one in every six couples who are trying to conceive. In at least half of all cases of Infertility, a malefactor is a primary or contributing cause. This means that about 10% of all men in the United States attempting to conceive suffer from Infertility.
The List of Companies - Male Infertility Market
- MERCK KGaA
- Sanofi
- Bayer AG
- Endo Pharmaceuticals Inc.
- SCSA Diagnostics, Inc.
- Andrology Solutions
- Halotech DNA
- INTAS PHARMACEUTICALS LTD.
- Cadila Pharmaceuticals Ltd.
- Vitrolife.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Oct 2020
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Oct 2020
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Oct 2020
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Oct 2020
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Oct 2020
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Oct 2020
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)